NL7613791A - Werkwijze voor de bereiding van polyhalogeen- steroiden. - Google Patents
Werkwijze voor de bereiding van polyhalogeen- steroiden.Info
- Publication number
- NL7613791A NL7613791A NL7613791A NL7613791A NL7613791A NL 7613791 A NL7613791 A NL 7613791A NL 7613791 A NL7613791 A NL 7613791A NL 7613791 A NL7613791 A NL 7613791A NL 7613791 A NL7613791 A NL 7613791A
- Authority
- NL
- Netherlands
- Prior art keywords
- polyhalogen
- steroids
- preparation
- polyhalogen steroids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1615175A CH621801A5 (en) | 1975-12-12 | 1975-12-12 | Process for the preparation of polyhalosteroids |
LU75903A LU75903A1 (xx) | 1976-09-29 | 1976-09-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL7613791A true NL7613791A (nl) | 1977-06-14 |
Family
ID=25717430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL7613791A NL7613791A (nl) | 1975-12-12 | 1976-12-10 | Werkwijze voor de bereiding van polyhalogeen- steroiden. |
Country Status (16)
Country | Link |
---|---|
US (1) | US4619921A (xx) |
JP (1) | JPS5289662A (xx) |
AT (2) | AT357703B (xx) |
AU (1) | AU508224B2 (xx) |
CA (1) | CA1056371A (xx) |
DD (1) | DD128683A5 (xx) |
DE (1) | DE2655570A1 (xx) |
DK (1) | DK143708C (xx) |
ES (1) | ES454120A1 (xx) |
FR (1) | FR2334363A1 (xx) |
GB (1) | GB1537130A (xx) |
HU (1) | HU175583B (xx) |
IE (1) | IE44473B1 (xx) |
IL (1) | IL51087A (xx) |
NL (1) | NL7613791A (xx) |
NZ (1) | NZ182836A (xx) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1209140B (it) * | 1979-11-16 | 1989-07-10 | Prochem Ets | 6 alfa-fluoro-prednisolone 17,21-diesteri. |
EP0078235A3 (de) * | 1981-10-23 | 1983-06-29 | Ciba-Geigy Ag | Dihalogenierte Steroide |
IT1319663B1 (it) * | 2000-11-17 | 2003-10-23 | Farmabios Srl | Processo per la preparazione di fluoro-steroidi. |
CA2473471A1 (en) | 2001-11-29 | 2003-06-12 | Taro Pharmaceuticals U.S.A., Inc. | Method for the preparation of 6-alpha-fluoro corticosteroids |
US20040138192A1 (en) * | 2003-01-13 | 2004-07-15 | Chemagis Ltd. | Crystalline forms of halobetasol propionate |
US7208485B2 (en) * | 2003-01-13 | 2007-04-24 | Chemagis Ltd. | Crystalline forms of halobetasol propionate |
AR045536A1 (es) * | 2003-08-29 | 2005-11-02 | Ranbaxy Lab Ltd | Inhibidores de la fosfodiesterasa tipo -iv |
EP1694655A2 (en) * | 2003-11-26 | 2006-08-30 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors |
WO2006110534A2 (en) | 2005-04-07 | 2006-10-19 | Taro Pharmaceuticals U.S.A., Inc. | A process for preparing a crystalline form of halobetasol propionate |
US7915286B2 (en) | 2005-09-16 | 2011-03-29 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
EP1948167A1 (en) * | 2005-10-19 | 2008-07-30 | Ranbaxy Laboratories, Ltd. | Compositions of phosphodiesterase type iv inhibitors |
US20090221664A1 (en) | 2005-10-19 | 2009-09-03 | Abhijit Ray | Pharmaceutical compositions of muscarinic receptor antagonists |
CA2664247A1 (en) * | 2006-09-22 | 2008-03-27 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type-iv |
WO2008035316A2 (en) * | 2006-09-22 | 2008-03-27 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors |
US20080207659A1 (en) * | 2007-02-15 | 2008-08-28 | Asit Kumar Chakraborti | Inhibitors of phosphodiesterase type 4 |
US20110130403A1 (en) * | 2007-03-14 | 2011-06-02 | Ranbaxy Laboratories Limited | Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors |
MX2009009793A (es) * | 2007-03-14 | 2009-10-16 | Ranbaxy Lab Ltd | Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa. |
EP2111861A1 (en) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
US8809307B2 (en) | 2010-11-22 | 2014-08-19 | Dow Pharmaceutical Sciences, Inc. | Pharmaceutical formulations containing corticosteroids for topical administration |
US11957753B2 (en) | 2010-11-22 | 2024-04-16 | Bausch Health Ireland Limited | Pharmaceutical formulations containing corticosteroids for topical administration |
US20140112959A1 (en) | 2012-10-18 | 2014-04-24 | MiCal Pharmaceuticals LLC - H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limite | Topical steroid composition and method |
AU2016279801B2 (en) | 2015-06-18 | 2021-09-09 | Valeant Pharmaceuticals North America | Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB924931A (xx) * | 1958-07-09 | |||
US3499016A (en) * | 1958-08-04 | 1970-03-03 | Upjohn Co | 6alpha-fluoro-16alpha-methyl derivatives of the pregnane series |
GB898292A (en) * | 1959-03-18 | 1962-06-06 | Upjohn Co | Improvements in or relating to steroids and the manufacture thereof |
CH510655A (de) * | 1967-11-17 | 1971-07-31 | Ciba Geigy Ag | Verfahren zur Herstellung neuer Halogenpregnadiene |
US3718673A (en) * | 1971-02-01 | 1973-02-27 | Du Pont | Process for the preparation of 21-chloro-6,6,9alpha-trifluoro-11beta, alpha, 17alpha-trihydroxy-1,4-pregnadien-3,20-dione 16,17-ketals and selected intermediates |
US4018918A (en) * | 1975-05-20 | 1977-04-19 | The Upjohn Company | Topical clindamycin preparations |
US3992422A (en) * | 1975-08-14 | 1976-11-16 | Schering Corporation | Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes |
-
1976
- 1976-12-08 DE DE19762655570 patent/DE2655570A1/de not_active Ceased
- 1976-12-09 NZ NZ182836A patent/NZ182836A/xx unknown
- 1976-12-09 GB GB51463/76A patent/GB1537130A/en not_active Expired
- 1976-12-10 AT AT913976A patent/AT357703B/de not_active IP Right Cessation
- 1976-12-10 FR FR7637257A patent/FR2334363A1/fr active Granted
- 1976-12-10 IL IL51087A patent/IL51087A/xx unknown
- 1976-12-10 HU HU76CI1705A patent/HU175583B/hu unknown
- 1976-12-10 CA CA267,605A patent/CA1056371A/en not_active Expired
- 1976-12-10 AU AU20472/76A patent/AU508224B2/en not_active Expired
- 1976-12-10 DK DK557876A patent/DK143708C/da not_active IP Right Cessation
- 1976-12-10 NL NL7613791A patent/NL7613791A/xx not_active Application Discontinuation
- 1976-12-10 IE IE2700/76A patent/IE44473B1/en unknown
- 1976-12-10 DD DD7600196266A patent/DD128683A5/xx unknown
- 1976-12-10 ES ES454120A patent/ES454120A1/es not_active Expired
- 1976-12-11 JP JP14932676A patent/JPS5289662A/ja active Pending
-
1979
- 1979-02-02 AT AT0081279A patent/AT363201B/de not_active IP Right Cessation
-
1984
- 1984-04-20 US US06/601,746 patent/US4619921A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IE44473B1 (en) | 1981-12-16 |
DK143708C (da) | 1982-03-15 |
DK143708B (da) | 1981-09-28 |
FR2334363A1 (fr) | 1977-07-08 |
CA1056371A (en) | 1979-06-12 |
US4619921A (en) | 1986-10-28 |
DK557876A (da) | 1977-06-13 |
AT363201B (de) | 1981-07-27 |
AU2047276A (en) | 1978-06-15 |
ES454120A1 (es) | 1978-02-16 |
AU508224B2 (en) | 1980-03-13 |
ATA913976A (de) | 1979-12-15 |
DE2655570A1 (de) | 1977-06-16 |
IE44473L (en) | 1977-06-12 |
ATA81279A (de) | 1980-12-15 |
IL51087A0 (en) | 1977-02-28 |
FR2334363B1 (xx) | 1980-03-14 |
AT357703B (de) | 1980-07-25 |
IL51087A (en) | 1980-06-30 |
JPS5289662A (en) | 1977-07-27 |
DD128683A5 (de) | 1977-12-07 |
GB1537130A (en) | 1978-12-29 |
HU175583B (hu) | 1980-09-28 |
NZ182836A (en) | 1979-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL7613791A (nl) | Werkwijze voor de bereiding van polyhalogeen- steroiden. | |
NL160311C (nl) | Werkwijze voor de bereiding van hardbare organopolysiloxan- materialen. | |
NL7613431A (nl) | Werkwijze voor de bereiding van o-hydroxybenzal- dehyden. | |
NL7605003A (nl) | Werkwijze voor de bereiding van polybutyleente- reftalaat. | |
NL7610066A (nl) | Werkwijze voor de bereiding van amidoxim deri- vaten. | |
NL7608674A (nl) | Werkwijze voor de bereiding van canthaxanthine. | |
NL7606994A (nl) | Werkwijze voor de bereiding van acylcyaniden. | |
NL184321C (nl) | Werkwijze voor de bereiding van steroiden. | |
NL7610059A (nl) | Werkwijze voor de bereiding van 4-oxo-4h-benzo- pyranderivaten. | |
NL7600512A (nl) | Werkwijze voor de bereiding van 2-aminobutanol-1. | |
NL7609939A (nl) | Werkwijze voor de bereiding van n-acylhydroxyaryl- glycinen. | |
NL7611424A (nl) | Werkwijze voor de bereiding van ethylvanadaat. | |
NL7602257A (nl) | Werkwijze voor de bereiding van histidine-deri- vaten. | |
NL184952C (nl) | Werkwijze voor de bereiding van cyclohexanonoxim. | |
NL7607505A (nl) | Werkwijze voor de bereiding van sulfamylbenzyl- aminen. | |
NL7611271A (nl) | Werkwijze voor de bereiding van 4-alkylthio- semicarbaziden. | |
NL7608796A (nl) | Werkwijze voor de bereiding van oxyranderivaten. | |
NL7602269A (nl) | Werkwijze voor de bereiding van entpolymeren. | |
NL7606651A (nl) | Werkwijze voor de bereiding van tertiaire fosfienoxyden. | |
NL186160C (nl) | Werkwijze voor de bereiding van theaspiran. | |
NL7608482A (nl) | Werkwijze voor de bereiding van glycosiden. | |
NL7607693A (nl) | Werkwijze voor de bereiding van tegen ontste- kingen werkende en bloeddrukverlagende prepara- ten. | |
NL7511696A (nl) | Werkwijze voor de bereiding van monochloor-s-tria- zine derivaten. | |
NL7602888A (nl) | Werkwijze voor de bereiding van 2-fenyl-indool- derivaten. | |
NL7600564A (nl) | Werkwijze voor de bereiding van schuimbare mengsels. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
A85 | Still pending on 85-01-01 | ||
BV | The patent application has lapsed |